Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 4 (2019), Article ID 4:IJCPP-144, 4 pages
https://doi.org/10.15344/2456-3501/2019/144
Case Report
Management of Heparin-Induced Thrombocytopenia in a Hemodialysis Patient with End Stage Renal Disease and Acute Heart Failure

Shu-Shan Wu1,2, Xiao-Yan Qiu1, Yu-ping Liu2, Ye Liu2, Ming-Ming Yan1* and Guo Ma2*

1Department of Clinical Pharmacy, Huashan Hospital, Fudan University, 12 Urumqi Middle Rd, Shanghai, P. R. China
2Department of Clinical Pharmacy, School of Pharmacy, Fudan University, 826 Zhangheng Rd, Shanghai, P. R. China
Dr. Guo Ma, Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, 201203, P.R. China. Tel.: 86-21-51980025; Fax: 86-21-51980025; E-mail: mg0328@fudan.edu.cn
Dr. Ming-Ming Yan, Department of Clinical Pharmacy, Huashan Hospital, Fudan University, 12 Urumqi Middle Rd, Shanghai, 200040, P. R. China ;Tel.: 86-21-52888712; Fax: 86-21-52888712; E-mail: yanmingming@huashan.org.cn
10 April 2019; 01 June 2019; 03 June 2019
Wu SS, Qiu XY, Liu YP, Liu Y, Yan MM, et al. (2019) Management of Heparin-Induced Thrombocytopenia in a Hemodialysis Patient with End Stage Renal Disease and Acute Heart Failure. Int J Clin Pharmacol Pharmacother 4: 144.doi: https://doi.org/10.15344/2456-3501/2019/144
This work was supported by grants from the National Natural Science Funds of China (81873078, 81374051), the Science and Research Program of Shanghai Municipal Health Commission (201740094), the Science and Research Program of Traditional Chinese Medicine of Shanghai Municipal Health Commission (2018YP001) and MHHFUSPFU Joint Research Fund (RO-MY201707), 2018 Medical Education Research Project of Chinese Society of Medical Education & Medical Education Committee of Chinese Association of Higher Education (2018A-N19014), 2019 Shanghai Education Science Research Project of Shanghai Education Committee (C19077), 2019 Fudan University Undergraduate Teaching Research and Reform Practice Projects (2019B020) to Guo Ma.
© 2019 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, et al. (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2: 3360-3392. View
  2. Frazer CA (2017) Heparin-InducedThrombocytopenia. J Infus Nurs 40: 98- 100. View
  3. Ahmed I, Majeed A, Powell R (2007) Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J 83: 575-582. View
  4. Bakchoul T, Greinacher A (2012) Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia. Ther Adv Hematol 3: 237-251. View
  5. Warkentin TE, Greinacher A, Koster A, Lincoff AM (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133: 340-380. View
  6. Kanaan AO, Al-Homsi AS (2009) Heparin-induced thrombocytopenia: Pathophysiology, diagnosis, and review of pharmacotherapy. J Pharm Pract 22: 149-157. View
  7. Greinacher A, Levy JH (2008) HIT happens: Diagnosing and evaluating the patient with heparin-induced thrombocytopenia. Anesth Analg 107: 356- 358. View
  8. Scully M, Gates C, Neave L (2016) How we manage patients with heparin induced thrombocytopenia. Br J Haematol 174: 9-15. View
  9. Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, et al. (2016) Heparin- Induced Thrombocytopenia: A Comprehensive Clinical Review. J Am Coll Cardiol 67: 2519-2532. View
  10. Matsuo T (2012) Management of Heparin-Induced Thrombocytopenia in Uremic Patients with Hemodialysis. Renal Failure - The Facts. View
  11. Cuker A, Gimotty PA, Crowther MA, Warkentin TE (2012) Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: A systematic review and meta-analysis. Blood 120: 4160-4167. View
  12. Lim JH, Kang KP, Lee S, Park SK, Kim W, et al. (2017) Recurrent heparininduced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report. Hemodial Int 21: 30-33. View
  13. Warkentin TE (2010) Agents for the treatment of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am 24: 755-775. View
  14. Tardy-Poncet B, Nguyen P, Thiranos JC, Morange PE, Biron-Andréani C, et al. (2015) Argatroban in the management of heparin-induced thrombocytopenia: A multicenter clinical trial. Crit Care 19: 396. View
  15. Quiñones-Ortiz L, Suárez-Laurés A, Pablos-de Pablo M, Robles V, Calzón- Blanco C, et al. (2014) Heparin-induced thrombocytopenia in haemodialysis treated with argatroban. Nefrologia 34: 670-674. View
  16. Chan KM, Cheung CY, Chau KF (2014) Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: A case report. Hemodial Int 18: 555-558. View
  17. Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, et al. (2014) Design of the rivaroxaban for heparin-induced thrombocytopenia study. J Thromb Thrombolysis 38: 485-492. View
  18. Bircan HA, Alanoglu EG (2016) Massive Pulmonary Embolism in a Patient with Heparin Induced Thrombocytopenia: Successful Treatment with Dabigatran. Eurasian J Med 48: 65-68. View
  19. Larsen PB, Jørgensen M, Friis-Hansen L, Ingeberg S (2015) Apixaban used for the management of heparin-induced thrombocytopenia in a 72-yearold woman with lung cancer. Clin Case Reports 3: 987-989. View
  20. Cuker A (2016) Management of the multiple phases of heparin-induced thrombocytopenia. Thromb Haemost 116: 835-842. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.